BIOMAT Database Logo BIOMAT Database Logo

Passive enhancement of canine renal allografts with polyspecific F(ab')2 fragments. 1974

S F Wren, and A C Martins, and U Von Haefen, and G J Busch, and G E Katske, and T L Koppenheffer, and T Shaipanich, and R E Wilson

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007112 Immunity, Maternally-Acquired Resistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk. Fetal Immunity, Maternally-Acquired,Maternally-Acquired Immunity,Neonatal Immunity, Maternally-Acquired,Immunity, Maternally Acquired,Fetal Immunities, Maternally-Acquired,Fetal Immunity, Maternally Acquired,Immunity, Maternally-Acquired Fetal,Immunity, Maternally-Acquired Neonatal,Maternally Acquired Immunities,Maternally Acquired Immunity,Maternally-Acquired Fetal Immunities,Maternally-Acquired Fetal Immunity,Maternally-Acquired Immunities,Maternally-Acquired Neonatal Immunities,Maternally-Acquired Neonatal Immunity,Neonatal Immunities, Maternally-Acquired,Neonatal Immunity, Maternally Acquired
D007140 Immunoglobulin Fab Fragments Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fab Fragment,Fab Fragments,Ig Fab Fragments,Immunoglobulins, Fab Fragment,Fab Immunoglobulin Fragments,Immunoglobulin Fab Fragment,Immunoglobulins, Fab,Fab Fragment Immunoglobulins,Fab Fragment, Immunoglobulin,Fab Fragments, Immunoglobulin,Fragment Immunoglobulins, Fab,Fragment, Fab,Immunoglobulin Fragments, Fab
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D001806 Blood Urea Nitrogen The urea concentration of the blood stated in terms of nitrogen content. Serum (plasma) urea nitrogen is approximately 12% higher than blood urea nitrogen concentration because of the greater protein content of red blood cells. Increases in blood or serum urea nitrogen are referred to as azotemia and may have prerenal, renal, or postrenal causes. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984) BUN,Nitrogen, Blood Urea,Urea Nitrogen, Blood
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog

Related Publications

S F Wren, and A C Martins, and U Von Haefen, and G J Busch, and G E Katske, and T L Koppenheffer, and T Shaipanich, and R E Wilson
Survival of canine renal allografts after treatment with polyspecific F(ab')2 fragments.
January 1973, Surgical forum,
S F Wren, and A C Martins, and U Von Haefen, and G J Busch, and G E Katske, and T L Koppenheffer, and T Shaipanich, and R E Wilson
Passive enhancement of cadaver renal allografts: a prospective randomized trial of F(ab')2 therapy.
March 1981, Transplantation proceedings,
S F Wren, and A C Martins, and U Von Haefen, and G J Busch, and G E Katske, and T L Koppenheffer, and T Shaipanich, and R E Wilson
Active enhancement of canine liver allografts with polyspecific antigen.
May 1978, Surgery, gynecology & obstetrics,
S F Wren, and A C Martins, and U Von Haefen, and G J Busch, and G E Katske, and T L Koppenheffer, and T Shaipanich, and R E Wilson
Enhancement of canine renal allografts. II. Studies with Fab fragments.
January 1976, Transactions of the American Association of Genito-Urinary Surgeons,
S F Wren, and A C Martins, and U Von Haefen, and G J Busch, and G E Katske, and T L Koppenheffer, and T Shaipanich, and R E Wilson
Evaluation of organ specificity in renal allograft enhancement with F(ab') 2 fragments.
March 1973, Transplantation proceedings,
S F Wren, and A C Martins, and U Von Haefen, and G J Busch, and G E Katske, and T L Koppenheffer, and T Shaipanich, and R E Wilson
Enhancement of rat renal allografts with F(ab')2 fragment of donor-specific antikidney serum.
July 1971, Surgery,
S F Wren, and A C Martins, and U Von Haefen, and G J Busch, and G E Katske, and T L Koppenheffer, and T Shaipanich, and R E Wilson
Successful enhancement of canine renal allografts.
September 1973, Investigative urology,
S F Wren, and A C Martins, and U Von Haefen, and G J Busch, and G E Katske, and T L Koppenheffer, and T Shaipanich, and R E Wilson
Active enhancement of canine renal allografts.
November 1970, The British journal of surgery,
S F Wren, and A C Martins, and U Von Haefen, and G J Busch, and G E Katske, and T L Koppenheffer, and T Shaipanich, and R E Wilson
Canine immunoglobulin F(ab')2 fragments protect cats against feline parvovirus virus infection.
September 2020, International immunopharmacology,
S F Wren, and A C Martins, and U Von Haefen, and G J Busch, and G E Katske, and T L Koppenheffer, and T Shaipanich, and R E Wilson
Photolinker-polymer-mediated immobilization of monoclonal antibodies, F(ab')2 and F(ab') fragments.
October 1994, Biotechnology and applied biochemistry,
Copied contents to your clipboard!